Alpha Teknova (NASDAQ:TKNO) Shares Gap Up – What’s Next?

Shares of Alpha Teknova, Inc. (NASDAQ:TKNO) gapped up before the market opened on Tuesday . The stock had previously closed at $9.18, but opened at $9.59. Alpha Teknova shares last traded at $9.67, with a volume of 60,236 shares traded.

Alpha Teknova Trading Down 3.9 %

The business’s fifty day moving average is $8.15 and its 200 day moving average is $6.07. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12.

Alpha Teknova (NASDAQ:TKNO) last issued its quarterly earnings results on Thursday, November 7th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of ($0.11) by ($0.04). The firm had revenue of $9.58 million during the quarter, compared to the consensus estimate of $9.30 million. Alpha Teknova had a negative net margin of 87.17% and a negative return on equity of 35.30%. During the same quarter last year, the firm earned ($0.34) earnings per share. Research analysts predict that Alpha Teknova, Inc. will post -0.58 earnings per share for the current fiscal year.

Institutional Trading of Alpha Teknova

A number of institutional investors have recently made changes to their positions in the business. China Universal Asset Management Co. Ltd. acquired a new stake in Alpha Teknova in the 4th quarter valued at $94,000. Whalen Wealth Management Inc. bought a new stake in Alpha Teknova during the fourth quarter worth about $240,000. Geode Capital Management LLC boosted its position in Alpha Teknova by 24.4% during the third quarter. Geode Capital Management LLC now owns 188,173 shares of the company’s stock valued at $911,000 after purchasing an additional 36,914 shares during the last quarter. State Street Corp grew its stake in Alpha Teknova by 249.3% in the third quarter. State Street Corp now owns 76,645 shares of the company’s stock valued at $371,000 after purchasing an additional 54,700 shares in the last quarter. Finally, Point72 Asset Management L.P. bought a new stake in shares of Alpha Teknova during the 3rd quarter worth approximately $1,483,000. Institutional investors own 13.81% of the company’s stock.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.